TAGLIAMENTO, MARCO
 Distribuzione geografica
Continente #
EU - Europa 343
Totale 343
Nazione #
IT - Italia 343
Totale 343
Città #
Genova 153
Rapallo 104
Genoa 79
Bordighera 7
Totale 343
Nome #
Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis, file e268c4c9-0e11-a6b7-e053-3a05fe0adea1 105
Correlation between B7-H4 and Survival of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab, file e268c4cd-9ba8-a6b7-e053-3a05fe0adea1 57
The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients, file e268c4cc-e1c1-a6b7-e053-3a05fe0adea1 55
Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the end of the debate, file e268c4ce-479b-a6b7-e053-3a05fe0adea1 22
Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatment, file e268c4cb-be83-a6b7-e053-3a05fe0adea1 21
Serum levels of VCAM-1 are associated with survival in patients treated with nivolumab for NSCLC, file e268c4cd-b5d3-a6b7-e053-3a05fe0adea1 13
Radiomic detection of EGFR mutations in NSCLC, file e268c4cd-0965-a6b7-e053-3a05fe0adea1 11
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients, file 036b3337-8850-4333-b5f8-0816dd8da198 10
Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer, file e268c4cc-def9-a6b7-e053-3a05fe0adea1 8
Prognostic Role of Soluble and Extracellular Vesicle-Associated PD-L1, B7-H3 and B7-H4 in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors, file 99e8d828-c8f7-4ffd-8de2-09b85aec2a08 4
Assessing the Impact of the COVID-19 Outbreak on the Attitudes and Practice of Italian Oncologists Toward Breast Cancer Care and Related Research Activities, file e268c4cc-6a06-a6b7-e053-3a05fe0adea1 3
Call for ensuring cancer care continuity during COVID-19 pandemic, file e268c4cc-a989-a6b7-e053-3a05fe0adea1 3
Afatinib and Erlotinib in the treatment of squamous-cell lung cancer, file e268c4cc-e924-a6b7-e053-3a05fe0adea1 3
Novel emerging molecular targets in non-small cell lung cancer, file e268c4ce-f36d-a6b7-e053-3a05fe0adea1 3
EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers, file 130cc417-61b1-4a70-ae3c-bbf301b4e888 2
Oncological care organisation during COVID-19 outbreak, file 4edcdf9c-2829-4c45-9739-c85451348fdf 2
Burning Questions in the Oncofertility Counseling of Young Breast Cancer Patients, file e268c4cc-cb0b-a6b7-e053-3a05fe0adea1 2
Performance of the oncomineTM Lung cfDNA assay for liquid biopsy by NGS of NSCLC patients in routine laboratory practice, file e268c4cd-1a85-a6b7-e053-3a05fe0adea1 2
Precision medicine for NSCLC in the era of immunotherapy: New biomarkers to select the most suitable treatment or the most suitable patient, file e268c4cd-1a8a-a6b7-e053-3a05fe0adea1 2
Update on the management of breast cancer during pregnancy, file e268c4cd-657f-a6b7-e053-3a05fe0adea1 2
Denosumab related osteonecrosis of the jaw: Unusual pattern with periosteal reaction, file 1f2a3007-758b-4381-a73c-ece117fc0c2e 1
Heterogeneity of treatment effects in malignant pleural mesothelioma, file 2f3cd2cd-3a13-4aa2-a011-131a6f72cb10 1
Comment on “Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta‑analysis”, file 635d595d-0591-4cf5-bc8b-2bc257125df7 1
Does perioperative immunotherapy reduce the risk of second primary cancers?, file 91c38b4d-a635-4c3f-88d4-cf180d78cba6 1
Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors, file b457e56f-efa4-463c-bacb-9eeb8ab29578 1
Nivolumab treatment in advanced lung cancer patient with chronic active hepatitis C and systemic lupus erythematosus., file e268c4ca-464d-a6b7-e053-3a05fe0adea1 1
Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study, file e268c4ca-9f33-a6b7-e053-3a05fe0adea1 1
Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer, file e268c4ca-d189-a6b7-e053-3a05fe0adea1 1
CIMAvax-EGF, a therapeutic non-small cell lung cancer vaccine, file e268c4cc-d50e-a6b7-e053-3a05fe0adea1 1
Microtubule-targeting agents in the treatment of non-small cell lung cancer: insights on new combination strategies and investigational compounds, file e268c4cc-d51b-a6b7-e053-3a05fe0adea1 1
The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer, file e268c4cc-e01e-a6b7-e053-3a05fe0adea1 1
Releasing the brake: safety profile of immune check-point inhibitors in non-small cell lung cancer, file e268c4cc-f3f9-a6b7-e053-3a05fe0adea1 1
Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer, file e268c4cc-f3fb-a6b7-e053-3a05fe0adea1 1
Totale 343
Categoria #
all - tutte 1.382
article - articoli 1.380
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.762


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202036 0 0 0 0 4 7 5 6 6 4 2 2
2020/202147 1 3 3 2 2 1 2 8 14 7 3 1
2021/202274 7 2 0 5 6 3 7 1 10 6 18 9
2022/2023121 1 2 16 14 13 27 4 14 6 6 14 4
2023/202465 0 2 3 6 11 3 11 11 2 7 9 0
Totale 343